{
    "Trade/Device Name(s)": [
        "BioPlex\u00ae 2200 Anti-CCP Kit"
    ],
    "Submitter Information": "Bio-Rad Laboratories, Inc.",
    "510(k) Number": "K112810",
    "Predicate Device Reference 510(k) Number(s)": [
        "K093954"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NHX"
    ],
    "Summary Letter Date": "September 26, 2011",
    "Summary Letter Received Date": "September 27, 2011",
    "Submission Date": "September 19, 2011",
    "Regulation Number(s)": [
        "21 CFR 866.5775"
    ],
    "Regulation Name(s)": [
        "Rheumatoid factor immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology",
        "autoimmune"
    ],
    "Analyte(s)": [
        "IgG antibodies to Cyclic Citrullinated Peptide (CCP)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Sodium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "BioPlex\u00ae 2200 System"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex flow immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for BioPlex 2200 Anti-CCP Kit, a multiplex flow immunoassay for IgG antibodies to CCP aiding rheumatoid arthritis diagnosis.",
    "Indications for Use Summary": "Multiplex flow immunoassay for semi-quantitative detection of IgG antibodies to cyclic citrullinated peptide in serum or plasma as an aid in the diagnosis of rheumatoid arthritis, for use with the BioPlex 2200 System.",
    "fda_folder": "Immunology"
}